Nutraceutical International Corp – IPO: ‘S-1/A’ on 1/28/98 – EX-11.1

As of:  Wednesday, 1/28/98   ·   Accession #:  950131-98-409   ·   File #:  333-41909

in

this entire Filing. an “Entity” Search.

Show

Documents searched

and

each “hit”. the 1st “hit”.

↓↑Hints

Initial Public Offering (IPO):  Pre-Effective Amendment to Registration Statement (General Form)   —   Form S-1
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-1/A       Amendment No. 1 to Form S-1                           86    523K 
 2: EX-3.1      Form of Amended and Restated Certificate              10     43K 
 3: EX-3.2      Form of By-Laws of the Registrant                     14     59K 
 4: EX-4.1      Form of Certificate Representing Common Stock          2     13K 
 5: EX-10.1     Revolving Credit and Term Loan Agreement             138    501K 
14: EX-10.10    Second Amendment to Warrants                           8     29K 
15: EX-10.11    Stock Option Agreement                                14     56K 
16: EX-10.12    Stock Option Agreement                                14     57K 
17: EX-10.13    Stock Option Agreement                                12     55K 
18: EX-10.14    Form of Area Sales Consultant Agreement               12     51K 
19: EX-10.15    Form of Transaction Services Agreement                 4     21K 
20: EX-10.16    Form of Termination Agreement                          4     17K 
21: EX-10.17    Form of Indemnification Agreement                      9     47K 
22: EX-10.18    1998 Stock Incentive Plan                             10     42K 
23: EX-10.19    Non-Employee Director Stock Option Plan                7     35K 
 6: EX-10.2     Waiver and Amendment to Revolving Credit              11     34K 
24: EX-10.20    Employee Stock Discount Purchase Plan                  7     33K 
 7: EX-10.3     Amended and Restated Stockholders Agreement           31     95K 
 8: EX-10.4     Amended and Restated Registration Agreement           29     89K 
 9: EX-10.5     Investor Agreement                                     9     42K 
10: EX-10.6     Consultant Stock Agreement                            24     77K 
11: EX-10.7     Executive Stock Agreement                             26     81K 
12: EX-10.8     Warrants                                              56    216K 
13: EX-10.9     First Amendment to Warrants                            5     20K 
25: EX-11.1     Computation of Pro Forma                               2±    12K 
26: EX-21.1     Subsidiaries of the Company                            1      9K 
27: EX-23.1     Consent of Price Waterhouse, LLP                       1      9K 

EX-11.1   —   Computation of Pro Forma

EX-11.1
TOC
↑Top
Previous
Next
↓Bottom
Just 1st
 
                                                                    EXHIBIT 11.1

NUTRACEUTICAL INTERNATIONAL CORPORATION 

COMPUATION FOR PRO FORMA EARNINGS PER SHARE 
(IN THOUSANDS, EXCEPT PER SHARE DATA) 
(UNAUDITED) 

                                                                  YEAR ENDED
                                                                   SEPTEMBER 30,
                                                                  1997
                                                                   -------------

PRO FORMA COMPUTATION OF PRIMARY EARNINGS                                       
PER SHARE:                                                                    
Net income.....................................................     $     4,248 
                                                                    ============
Weighted average number of common stock and common stock                        
equivalents outstanding.......................................       9,337,875
Net additional shares issuable in connection with stock options                 
and warrants pursuant to the treasury stock method............       1,447,458
                                                                    ------------

Weighted average number of common stock and common                              
stock equivalents.............................................      10,758,333
                                                                    ============
Pro forma net income per share.................................            0.39 
                                                                    ============

SUPPLEMENTAL PRO FORMA COMPUTATION OF                                           
PRIMARY EARNINGS PER SHARE:                                                   
Weighted average number of common stock and common                              
stock equivalents.............................................      10,785,333
Shares to be issued............................................       2,000,000 
                                                                    ------------
                                                                    12,785,333
                                                                    ============

Net income:                                                                     
As reported...................................................     $     4,248
Add: interest paid............................................           2,360
 Less: tax effect..............................................            (932)
                                                                    ------------
As adjusted...................................................     $     5,676
                                                                    ============
Supplemental pro forma net income per share....................     $      0.44 

PRO FORMA COMPUTATION OF FULLY DILUTED                                          
EARNINGS PER SHARE:                                                           
Net income.....................................................     $     4,248 
                                                                    ============
Weighted average number of common stock and common                              
stock equivalents outstanding.................................       9,337,875
Net additional shares issuable in connection with stock options                 
and warrants on a fully diluted basis pursuant to the                         
treasury stock method.........................................       1,447,458
                                                                    ------------
                                                                    10,785,333
                                                                    ============
Pro forma fully diluted net income per share...................     $      0.39 
                                                                    ============

Dates Referenced Herein

This ‘S-1/A’ Filing		Date		Other Filings
Filed on:		1/28/98		None on these Dates
		9/30/97
				List all Filings